Logo image
Back
Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia
Journal article   Open access   Peer reviewed

Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia

I. R. de Oliveira, V. B. Powell, A. Wenzel, M. Caldas, C. Seixas, C. Almeida, T. Bonfim, M. C. Grangeon, M. Castro, A. Galvao, …
Journal of clinical pharmacy and therapeutics, v 37(3), pp 328-334
01 Jun 2012
DOI: https://doi.org/10.1111/j.1365-2710.2011.01299.x
PMID: 21955037
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1111/j.1365-2710.2011.01299.xView
Published, Version of Record (VoR)Open Access (License Unspecified),  Open

Abstract

Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology
What is known and Background: Social anxiety disorder (SAD) often follows a chronic course and is associated with substantial impairment in functioning. Although results from clinical trials clearly establish evidence for efficacy of cognitive behavioural therapy in treating this disorder, up to 50% of patients with SAD show little or no improvement. Thus, new approaches that have promised in improving the efficacy of treatment for SAD are needed. One such approach is the trial-based thought record (TBTR), which targets the restructuring of patients core beliefs. Objective: To determine whether patients receiving TBTR would report fewer symptoms of social anxiety and general psychiatric distress following treatment, relative to conventional cognitive therapy (CCT). Methods: A two-arm randomized trial comparing TBTR (n = 17) with a set of CCT techniques (n = 19), which included the standard seven-column dysfunctional thought record and the positive data log in SAD patients according to DSM-IV. Results: Scores on many outcome measures decreased significantly across the course of treatment in both groups (P < 0.001), including the Liebowitz Social Anxiety Scale, Fear of Negative Evaluation Scale (FNE), Social Avoidance and Distress Scale (SADS), Beck Anxiety Inventory, and Clinical Global Impression Improvement. In addition, a one-way ancova, taking baseline values as covariates, showed that TBTR was significantly more efficacious than CCT in reducing the scores of FNE (P = 0.01 at mid-treatment and P = 0.004 at post-treatment), and SADS (P = 0.03 at post-treatment). What is new and Conclusion: This study provides preliminary evidence that TBTR is at least as efficacious as CCT in reducing symptoms of SAD, pointing to the need for additional studies of TBTR in SAD and other psychiatric disorders.

Metrics

7 Record Views
27 citations in Web of Science
36 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image